Mar 04, 2022 9:00am EST Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) View Press Release
Feb 10, 2022 10:45pm EST Surgalign Holdings, Inc. Announces Pricing of $20 Million Public Offering View Press Release
Feb 10, 2022 4:05pm EST Surgalign Holdings, Inc. Announces Proposed Public Offering View Press Release
Feb 03, 2022 9:00am EST Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) View Press Release
Jan 18, 2022 7:00am EST Surgalign Receives FDA Clearance for HOLO Portal™ System, the World’s First AI-driven AR Guidance System for Spine Surgery and Reports Preliminary Fourth Quarter and Full Year 2021 Results View Press Release
Jan 13, 2022 6:00pm EST Surgalign Holdings, Inc. to Participate at the Sidoti Virtual Small Cap Conference View Press Release
Jan 06, 2022 9:00am EST Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) View Press Release
Jan 05, 2022 9:00am EST Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc. View Press Release
Dec 20, 2021 4:30pm EST Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference View Press Release
Dec 03, 2021 9:00am EST Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) View Press Release
